Amitriptilin (Turkish Wikipedia)
Analysis of information sources in references of the Wikipedia article "Amitriptilin" in Turkish language version.
refsWebsite
Global rank
Turkish rank
1st place
1st place
6th place
6th place
3,912th place
2,106th place
low place
low place
719th place
582nd place
3,823rd place
3,999th place
102nd place
447th place
3,097th place
3,478th place
low place
low place
3,984th place
3,256th place
18th place
47th place
low place
low place
anesthesia-analgesia.org
- Punke MA, Friederich P (May 2007). "Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels". Anesthesia and Analgesia. 104 (5): 1256-64, tables of contents. doi:10.1213/01.ane.0000260310.63117.a2
. PMID 17456683. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2009.
archive.org
- "Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics". Journal of Clinical Psychopharmacology. 28 (1): 1-4. February 2008. doi:10.1097/jcp.0b013e3181627b60. PMID 18204333.
- Voican CS, Corruble E, Naveau S, Perlemuter G (April 2014). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404-415. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450.
- Joint Formulary Committee (2013). British National Formulary (BNF)
(65. bas.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8. - Cusack B, Nelson A, Richelson E (May 1994). "Binding of antidepressants to human brain receptors: focus on newer generation compounds". Psychopharmacology. 114 (4): 559-565. doi:10.1007/bf02244985. PMID 7855217.
- Peroutka SJ (May 1988). "Antimigraine drug interactions with serotonin receptor subtypes in human brain". Annals of Neurology. 23 (5): 500-504. doi:10.1002/ana.410230512. PMID 2898916.
- Pälvimäki EP, Roth BL, Majasuo H, Laakso A, Kuoppamäki M, Syvälahti E, Hietala J (August 1996). "Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor". Psychopharmacology. 126 (3): 234-240. doi:10.1007/bf02246453. PMID 8876023.
- Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (August 1993). "Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype". The Journal of Biological Chemistry. 268 (24): 18200-18204. doi:10.1016/S0021-9258(17)46830-X . PMID 8394362.
- Stanton T, Bolden-Watson C, Cusack B, Richelson E (June 1993). "Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics". Biochemical Pharmacology. 45 (11): 2352-2354. doi:10.1016/0006-2952(93)90211-e. PMID 8100134.
- Venkatakrishnan K, Schmider J, Harmatz JS, Ehrenberg BL, von Moltke LL, Graf JA, Mertzanis P, Corbett KE, Rodriguez MC, Shader RI, Greenblatt DJ (October 2001). "Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies". Journal of Clinical Pharmacology. 41 (10): 1043-1054. doi:10.1177/00912700122012634. PMID 11583471.
clincalc.com
- "The Top 300 of 2019". ClinCalc. 16 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ekim 2021.
- "Amitriptyline - Drug Usage Statistics". ClinCalc. 30 Nisan 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ekim 2021.
doi.org
- "Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs". Drugs. 80 (4): 363-384. March 2020. doi:10.1007/s40265-020-01259-2. PMID 32040849.
- "EULAR revised recommendations for the management of fibromyalgia". Ann Rheum Dis. 76 (2): 318-328. February 2017. doi:10.1136/annrheumdis-2016-209724. PMID 27377815.
- "Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society". Neurology. 78 (17): 1337-45. April 2012. doi:10.1212/WNL.0b013e3182535d20. PMC 3335452 $2. PMID 22529202.
- "Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine". CNS Drugs. 31 (5): 389-403. May 2017. doi:10.1007/s40263-017-0430-3. PMID 28405886.
- "Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics". Journal of Clinical Psychopharmacology. 28 (1): 1-4. February 2008. doi:10.1097/jcp.0b013e3181627b60. PMID 18204333.
- Leucht, Claudia; Huhn, Maximilian; Leucht, Stefan (12 Aralık 2012). Cochrane Common Mental Disorders Group (Ed.). "Amitriptyline versus placebo for major depressive disorder". Cochrane Database of Systematic Reviews (İngilizce). doi:10.1002/14651858.CD009138.pub2.
- Zhou X, Michael KD, Liu Y, Del Giovane C, Qin B, Cohen D, Gentile S, Xie P (November 2014). "Systematic review of management for treatment-resistant depression in adolescents". BMC Psychiatry. 14: 340. doi:10.1186/s12888-014-0340-6 . PMC 4254264 $2. PMID 25433401.
- Riblet N, Larson R, Watts BV, Holtzheimer P (2014). "Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis". General Hospital Psychiatry. 36 (5): 466-473. doi:10.1016/j.genhosppsych.2014.05.010. PMID 24950919.
- Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C (October 2011). "The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease". Movement Disorders. 26 (Supply 3): S42-S80. doi:10.1002/mds.23884. PMC 4020145 $2. PMID 22021174.
- Liampas A, Rekatsina M, Vadalouca A, Paladini A, Varrassi G, Zis P (June 2021). "Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review". Pain and Therapy. 10 (1): 55-68. doi:10.1007/s40122-020-00210-3 . PMC 8119529 $2. PMID 33145709.
- Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice AS, Bouhassira D, Bennett DL, Selvarajah D (August 2022). "Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial". Lancet. 400 (10353): 680-690. doi:10.1016/s0140-6736(22)01472-6. PMC 9418415 $2. PMID 36007534.
- "Combination therapy for painful diabetic neuropathy is safe and effective". NIHR Evidence (İngilizce). 6 Nisan 2023. doi:10.3310/nihrevidence_57470. 28 Nisan 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- Sudoh Y, Cahoon EE, Gerner P, Wang GK (May 2003). "Tricyclic antidepressants as long-acting local anesthetics". Pain. 103 (1–2): 49-55. doi:10.1016/s0304-3959(02)00375-5. PMID 12749958.
- Sommer C, Alten R, Bär KJ, Bernateck M, Brückle W, Friedel E, Henningsen P, Petzke F, Tölle T, Üçeyler N, Winkelmann A, Häuser W (June 2017). "[Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]". Schmerz (Almanca). 31 (3): 274-284. doi:10.1007/s00482-017-0207-0. PMID 28493231.
- Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I (February 2018). "Combination pharmacotherapy for the treatment of fibromyalgia in adults". The Cochrane Database of Systematic Reviews. 2 (2): CD010585. doi:10.1002/14651858.CD010585.pub2. PMC 6491103 $2. PMID 29457627.
- van den Beuken-van Everdingen MH, de Graeff A, Jongen JL, Dijkstra D, Mostovaya I, Vissers KC (March 2017). "Pharmacological Treatment of Pain in Cancer Patients: The Role of Adjuvant Analgesics, a Systematic Review". Pain Practice. 17 (3): 409-419. doi:10.1111/papr.12459. PMID 27207115.
- Loder E, Rizzoli P (November 2018). "Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018". Headache. 58 (Suppl 3): 218-229. doi:10.1111/head.13375. PMID 30137671.
- Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Victorio MC, Yonker M, Zanitsch H, Hershey AD (September 2019). "Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society". Neurology. 93 (11): 500-509. doi:10.1212/WNL.0000000000008105. PMC 6746206 $2. PMID 31413170.
- Do TM, Unis GD, Kattar N, Ananth A, McCoul ED (June 2021). "Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis". The Laryngoscope. 131 (6): 1235-1253. doi:10.1002/lary.29162. PMID 33037835.
- Trinkley KE, Nahata MC (2014). "Medication management of irritable bowel syndrome". Digestion. 89 (4): 253-267. doi:10.1159/000362405 . PMID 24992947.
- Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA (November 2023). "Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial". Lancet. 402 (10414): 1773-1785. doi:10.1016/s0140-6736(23)01523-4. PMID 37858323.
- "Irritable bowel syndrome: low-dose antidepressant improves symptoms". NIHR Evidence. National Institute for Health and Care Research (NIHR). 26 Mart 2024. doi:10.3310/nihrevidence_62555. 18 Mayıs 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- Venkatesan T, Levinthal DJ, Tarbell SE, Jaradeh SS, Hasler WL, Issenman RM, Adams KA, Sarosiek I, Stave CD, Sharaf RN, Sultan S, Li BU (June 2019). "Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association". Neurogastroenterology and Motility. 31 (Suppl 2): e13604. doi:10.1111/nmo.13604. PMC 6899751 $2. PMID 31241819.
- Caldwell PH, Sureshkumar P, Wong WC (January 2016). "Tricyclic and related drugs for nocturnal enuresis in children". The Cochrane Database of Systematic Reviews. 2016 (1): CD002117. doi:10.1002/14651858.CD002117.pub2. PMC 8741207 $2. PMID 26789925.
- Giusto LL, Zahner PM, Shoskes DA (July 2018). "An evaluation of the pharmacotherapy for interstitial cystitis". Expert Opinion on Pharmacotherapy. 19 (10): 1097-1108. doi:10.1080/14656566.2018.1491968. PMID 29972328.
- Colemeadow J, Sahai A, Malde S (2020). "Clinical Management of Bladder Pain Syndrome/Interstitial Cystitis: A Review on Current Recommendations and Emerging Treatment Options". Research and Reports in Urology. 12: 331-343. doi:10.2147/RRU.S238746 . PMC 7455607 $2. PMID 32904438.
- Everitt H, McDermott L, Leydon G, Yules H, Baldwin D, Little P (February 2014). "GPs' management strategies for patients with insomnia: a survey and qualitative interview study". The British Journal of General Practice. 64 (619): e112-e119. doi:10.3399/bjgp14X677176. PMC 3905408 $2. PMID 24567616.
- Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CC, Wilson S (May 2018). "Antidepressants for insomnia in adults". The Cochrane Database of Systematic Reviews. 2018 (5): CD010753. doi:10.1002/14651858.CD010753.pub2. PMC 6494576 $2. PMID 29761479.
- Pecknold JC, Luthe L (1989). "Trimipramine, anxiety, depression and sleep". Drugs. 38 (Suppl 1): 25-31; discussion 49-50. doi:10.2165/00003495-198900381-00007. PMID 2693052.
- Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M (September 2002). "Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study". Pharmacopsychiatry. 35 (5): 165-74. doi:10.1055/s-2002-34119. PMID 12237787.
- Berger M, Gastpar M (1996). "Trimipramine: a challenge to current concepts on antidepressives". European Archives of Psychiatry and Clinical Neuroscience. 246 (5): 235-9. doi:10.1007/BF02190274. PMID 8863001.
- Klein T, Woo TM, Panther S, Odom-Maryon T, Daratha K (2019). "Somnolence-Producing Agents: A 5-Year Study of Prescribing for Medicaid-Insured Children With Attention Deficit Hyperactivity Disorder". Journal of Pediatric Health Care. 33 (3): e1-e8. doi:10.1016/j.pedhc.2018.10.002. PMID 30630642.
- Domecq JP, Prutsky G, Leppin A, Sonbol MB, Altayar O, Undavalli C, Wang Z, Elraiyah T, Brito JP, Mauck KF, Lababidi MH, Prokop LJ, Asi N, Wei J, Fidahussein S, Montori VM, Murad MH (February 2015). "Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis". The Journal of Clinical Endocrinology and Metabolism. 100 (2): 363-370. doi:10.1210/jc.2014-3421. PMC 5393509 $2. PMID 25590213.
- Leucht C, Huhn M, Leucht S (December 2012). "Amitriptyline versus placebo for major depressive disorder". The Cochrane Database of Systematic Reviews. 12: CD009138. doi:10.1002/14651858.CD009138.pub2. PMID 23235671.
- Chen LW, Chen MY, Lian ZP, Lin HS, Chien CC, Yin HL, Chu YH, Chen KY (March 2018). "Amitriptyline and Sexual Function: A Systematic Review Updated for Sexual Health Practice". American Journal of Men's Health. 12 (2): 370-379. doi:10.1177/1557988317734519. PMC 5818113 $2. PMID 29019272.
- Voican CS, Corruble E, Naveau S, Perlemuter G (April 2014). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404-415. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450.
- Zemrak WR, Kenna GA (June 2008). "Association of antipsychotic and antidepressant drugs with Q-T interval prolongation". American Journal of Health-System Pharmacy. 65 (11): 1029-1038. doi:10.2146/ajhp070279. PMID 18499875. 21 Aralık 2016 tarihinde kaynağından arşivlendi.
- Campleman SL, Brent J, Pizon AF, Shulman J, Wax P, Manini AF (December 2020). "Drug-specific risk of severe QT prolongation following acute drug overdose". Clinical Toxicology. 58 (12): 1326-1334. doi:10.1080/15563650.2020.1746330. PMC 7541562 $2. PMID 32252558.
- Hefner G, Hahn M, Hohner M, Roll SC, Klimke A, Hiemke C (January 2019). "QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric Inpatients". Pharmacopsychiatry. 52 (1): 38-43. doi:10.1055/s-0044-102009. PMID 29466824.
- Tatsumi M, Groshan K, Blakely RD, Richelson E (December 1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". European Journal of Pharmacology. 340 (2–3): 249-258. doi:10.1016/s0014-2999(97)01393-9. PMID 9537821.
- Cusack B, Nelson A, Richelson E (May 1994). "Binding of antidepressants to human brain receptors: focus on newer generation compounds". Psychopharmacology. 114 (4): 559-565. doi:10.1007/bf02244985. PMID 7855217.
- Peroutka SJ (May 1988). "Antimigraine drug interactions with serotonin receptor subtypes in human brain". Annals of Neurology. 23 (5): 500-504. doi:10.1002/ana.410230512. PMID 2898916.
- Peroutka SJ (August 1986). "Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex". Journal of Neurochemistry. 47 (2): 529-540. doi:10.1111/j.1471-4159.1986.tb04532.x. PMID 2942638.
- Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H (May 1996). "Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache?". The European Journal of Neuroscience. 8 (5): 959-967. doi:10.1111/j.1460-9568.1996.tb01583.x. PMID 8743744.
- Pälvimäki EP, Roth BL, Majasuo H, Laakso A, Kuoppamäki M, Syvälahti E, Hietala J (August 1996). "Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor". Psychopharmacology. 126 (3): 234-240. doi:10.1007/bf02246453. PMID 8876023.
- Sánchez C, Hyttel J (August 1999). "Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding". Cellular and Molecular Neurobiology. 19 (4): 467-489. doi:10.1023/a:1006986824213. PMID 10379421.
- Schmidt AW, Hurt SD, Peroutka SJ (November 1989). "'[3H]quipazine' degradation products label 5-HT uptake sites". European Journal of Pharmacology. 171 (1): 141-143. doi:10.1016/0014-2999(89)90439-1. PMID 2533080.
- Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (January 1996). "Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor". Journal of Neurochemistry. 66 (1): 47-56. doi:10.1046/j.1471-4159.1996.66010047.x. PMID 8522988.
- Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD (December 2003). "Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling". Molecular Pharmacology. 64 (6): 1295-1308. doi:10.1124/mol.64.6.1295. PMID 14645659.
- Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (August 1993). "Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype". The Journal of Biological Chemistry. 268 (24): 18200-18204. doi:10.1016/S0021-9258(17)46830-X . PMID 8394362.
- Nojimoto FD, Mueller A, Hebeler-Barbosa F, Akinaga J, Lima V, Kiguti LR, Pupo AS (2010). "The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors". Neuropharmacology. 59 (1–2): 49-57. doi:10.1016/j.neuropharm.2010.03.015. PMID 20363235.
- Proudman RG, Pupo AS, Baker JG (August 2020). "The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors". Pharmacology Research & Perspectives. 8 (4): e00602. doi:10.1002/prp2.602. PMC 7327383 $2. PMID 32608144.
- Fallarero A, Pohjanoksa K, Wissel G, Parkkisenniemi-Kinnunen UM, Xhaard H, Scheinin M, Vuorela P (December 2012). "High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors". European Journal of Pharmaceutical Sciences. 47 (5): 941-951. doi:10.1016/j.ejps.2012.08.021. PMID 22982401.
- von Coburg Y, Kottke T, Weizel L, Ligneau X, Stark H (January 2009). "Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics". Bioorganic & Medicinal Chemistry Letters. 19 (2): 538-542. doi:10.1016/j.bmcl.2008.09.012. PMID 19091563.
- Appl H, Holzammer T, Dove S, Haen E, Strasser A, Seifert R (February 2012). "Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics". Naunyn-Schmiedeberg's Archives of Pharmacology. 385 (2): 145-170. doi:10.1007/s00210-011-0704-0. PMID 22033803.
- Ghoneim OM, Legere JA, Golbraikh A, Tropsha A, Booth RG (October 2006). "Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes". Bioorganic & Medicinal Chemistry. 14 (19): 6640-6658. doi:10.1016/j.bmc.2006.05.077. PMID 16782354.
- Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF (March 2001). "Discovery of a novel member of the histamine receptor family". Molecular Pharmacology. 59 (3): 427-433. doi:10.1124/mol.59.3.427. PMID 11179435. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2019.
- Stanton T, Bolden-Watson C, Cusack B, Richelson E (June 1993). "Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics". Biochemical Pharmacology. 45 (11): 2352-2354. doi:10.1016/0006-2952(93)90211-e. PMID 8100134.
- Bymaster FP, Nelson DL, DeLapp NW, Falcone JF, Eckols K, Truex LL, Foreman MM, Lucaites VL, Calligaro DO (May 1999). "Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro". Schizophrenia Research. 37 (1): 107-122. doi:10.1016/s0920-9964(98)00146-7. PMID 10227113.
- Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JF (November 1986). "1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs". Proceedings of the National Academy of Sciences of the United States of America. 83 (22): 8784-8788. Bibcode:1986PNAS...83.8784W. doi:10.1073/pnas.83.22.8784 . PMC 387016 $2. PMID 2877462.
- Werling LL, Keller A, Frank JG, Nuwayhid SJ (October 2007). "A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder". Experimental Neurology. 207 (2): 248-257. doi:10.1016/j.expneurol.2007.06.013. PMID 17689532.
- Jo SH, Youm JB, Lee CO, Earm YE, Ho WK (April 2000). "Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline". British Journal of Pharmacology. 129 (7): 1474-1480. doi:10.1038/sj.bjp.0703222. PMC 1571977 $2. PMID 10742304.
- Yamakawa Y, Furutani K, Inanobe A, Ohno Y, Kurachi Y (February 2012). "Pharmacophore modeling for hERG channel facilitation". Biochemical and Biophysical Research Communications. 418 (1): 161-166. doi:10.1016/j.bbrc.2011.12.153. PMID 22244872.
- Fu L, Wang S, Wang X, Wang P, Zheng Y, Yao D, Guo M, Zhang L, Ouyang L (December 2016). "Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer". Scientific Reports. 6 (1): 3. doi:10.1038/s41598-016-0007-2. PMC 5431371 $2. PMID 28442756.
- Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K (June 2009). "Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity". Chemistry & Biology. 16 (6): 644-656. doi:10.1016/j.chembiol.2009.05.010. PMC 2844702 $2. PMID 19549602.
- Horishita T, Yanagihara N, Ueno S, Okura D, Horishita R, Minami T, Ogata Y, Sudo Y, Uezono Y, Sata T, Kawasaki T (December 2017). "Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes". Naunyn-Schmiedeberg's Archives of Pharmacology. 390 (12): 1255-1270. doi:10.1007/s00210-017-1424-x. PMID 28905186.
- Atkin TA, Maher CM, Gerlach AC, Gay BC, Antonio BM, Santos SC, Padilla KM, Rader J, Krafte DS, Fox MA, Stewart GR, Petrovski S, Devinsky O, Might M, Petrou S, Goldstein DB (April 2018). "A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy". Epilepsia. 59 (4): 802-813. doi:10.1111/epi.14037 . PMID 29574705.
- Punke MA, Friederich P (May 2007). "Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels". Anesthesia and Analgesia. 104 (5): 1256-64, tables of contents. doi:10.1213/01.ane.0000260310.63117.a2 . PMID 17456683. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2009.
- Villatoro-Gómez K, Pacheco-Rojas DO, Moreno-Galindo EG, Navarro-Polanco RA, Tristani-Firouzi M, Gazgalis D, Cui M, Sánchez-Chapula JA, Ferrer T (June 2018). "Molecular determinants of Kv7.1/KCNE1 channel inhibition by amitriptyline". Biochemical Pharmacology. 152: 264-271. doi:10.1016/j.bcp.2018.03.016. PMID 29621539.
- Jo SH, Youm JB, Lee CO, Earm YE, Ho WK (April 2000). "Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline". British Journal of Pharmacology. 129 (7): 1474-1480. doi:10.1038/sj.bjp.0703222. PMC 1571977 $2. PMID 10742304.
- McClure EW, Daniels RN (February 2021). "Classics in Chemical Neuroscience: Amitriptyline". ACS Chemical Neuroscience. 12 (3): 354-362. doi:10.1021/acschemneuro.0c00467. PMID 33438398.
- Schulz P, Dick P, Blaschke TF, Hollister L (1985). "Discrepancies between pharmacokinetic studies of amitriptyline". Clinical Pharmacokinetics. 10 (3): 257-268. doi:10.2165/00003088-198510030-00005. PMID 3893842.
- Breyer-Pfaff U (October 2004). "The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man". Drug Metabolism Reviews. 36 (3–4): 723-746. doi:10.1081/dmr-200033482. PMID 15554244.
- Venkatakrishnan K, Schmider J, Harmatz JS, Ehrenberg BL, von Moltke LL, Graf JA, Mertzanis P, Corbett KE, Rodriguez MC, Shader RI, Greenblatt DJ (October 2001). "Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies". Journal of Clinical Pharmacology. 41 (10): 1043-1054. doi:10.1177/00912700122012634. PMID 11583471.
- Nordin C, Bertilsson L (January 1995). "Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline". Clinical Pharmacokinetics. 28 (1): 26-40. doi:10.2165/00003088-199528010-00004. PMID 7712660.
- Dawlilng S, Lynn K, Rosser R, Braithwaite R (July 1981). "The pharmacokinetics of nortriptyline in patients with chronic renal failure". British Journal of Clinical Pharmacology. 12 (1): 39-45. doi:10.1111/j.1365-2125.1981.tb01852.x. PMC 1401753 $2. PMID 7248140.
drugs.com
- "Amitriptyline Hydrochloride". The American Society of Health-System Pharmacists. 24 Eylül 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Eylül 2014.
- "Amitriptyline Uses, Dosage, Side Effects, Warnings". Drugs.com (İngilizce). 19 Haziran 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
handle.net
hdl.handle.net
- Organization WH (2021). World Health Organization model list of essential medicines: 22nd list (2021). Cenevre: World Health Organization. hdl:10665/345533 . WHO/MHP/HPS/EML/2021.02.
harvard.edu
adsabs.harvard.edu
- Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JF (November 1986). "1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs". Proceedings of the National Academy of Sciences of the United States of America. 83 (22): 8784-8788. Bibcode:1986PNAS...83.8784W. doi:10.1073/pnas.83.22.8784 . PMC 387016 $2. PMID 2877462.
medicines.org.uk
- "Amitriptyline Tablets BP 50mg – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Actavis UK Ltd. 24 Mart 2013. 3 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Aralık 2013.
medscape.com
medscape.com
- Zemrak WR, Kenna GA (June 2008). "Association of antipsychotic and antidepressant drugs with Q-T interval prolongation". American Journal of Health-System Pharmacy. 65 (11): 1029-1038. doi:10.2146/ajhp070279. PMID 18499875. 21 Aralık 2016 tarihinde kaynağından arşivlendi.
reference.medscape.com
- "Pamelor, Aventyl (nortriptyline) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. 3 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 2 Aralık 2013.
merckmanuals.com
- "Parkinson's disease". merckmanuals.com. Merck Sharp & Dohme Corp. August 2007. 18 Kasım 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Aralık 2013.
nationalmssociety.org
- "Elavil for MS". nationalmssociety.org. 7 Temmuz 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Temmuz 2023.
nih.gov
ncbi.nlm.nih.gov
- "Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs". Drugs. 80 (4): 363-384. March 2020. doi:10.1007/s40265-020-01259-2. PMID 32040849.
- "EULAR revised recommendations for the management of fibromyalgia". Ann Rheum Dis. 76 (2): 318-328. February 2017. doi:10.1136/annrheumdis-2016-209724. PMID 27377815.
- "Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society". Neurology. 78 (17): 1337-45. April 2012. doi:10.1212/WNL.0b013e3182535d20. PMC 3335452 $2. PMID 22529202.
- "Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine". CNS Drugs. 31 (5): 389-403. May 2017. doi:10.1007/s40263-017-0430-3. PMID 28405886.
- "Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics". Journal of Clinical Psychopharmacology. 28 (1): 1-4. February 2008. doi:10.1097/jcp.0b013e3181627b60. PMID 18204333.
- Zhou X, Michael KD, Liu Y, Del Giovane C, Qin B, Cohen D, Gentile S, Xie P (November 2014). "Systematic review of management for treatment-resistant depression in adolescents". BMC Psychiatry. 14: 340. doi:10.1186/s12888-014-0340-6 . PMC 4254264 $2. PMID 25433401.
- Riblet N, Larson R, Watts BV, Holtzheimer P (2014). "Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis". General Hospital Psychiatry. 36 (5): 466-473. doi:10.1016/j.genhosppsych.2014.05.010. PMID 24950919.
- Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C (October 2011). "The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease". Movement Disorders. 26 (Supply 3): S42-S80. doi:10.1002/mds.23884. PMC 4020145 $2. PMID 22021174.
- Liampas A, Rekatsina M, Vadalouca A, Paladini A, Varrassi G, Zis P (June 2021). "Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review". Pain and Therapy. 10 (1): 55-68. doi:10.1007/s40122-020-00210-3 . PMC 8119529 $2. PMID 33145709.
- Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice AS, Bouhassira D, Bennett DL, Selvarajah D (August 2022). "Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial". Lancet. 400 (10353): 680-690. doi:10.1016/s0140-6736(22)01472-6. PMC 9418415 $2. PMID 36007534.
- Sudoh Y, Cahoon EE, Gerner P, Wang GK (May 2003). "Tricyclic antidepressants as long-acting local anesthetics". Pain. 103 (1–2): 49-55. doi:10.1016/s0304-3959(02)00375-5. PMID 12749958.
- Sommer C, Alten R, Bär KJ, Bernateck M, Brückle W, Friedel E, Henningsen P, Petzke F, Tölle T, Üçeyler N, Winkelmann A, Häuser W (June 2017). "[Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]". Schmerz (Almanca). 31 (3): 274-284. doi:10.1007/s00482-017-0207-0. PMID 28493231.
- Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I (February 2018). "Combination pharmacotherapy for the treatment of fibromyalgia in adults". The Cochrane Database of Systematic Reviews. 2 (2): CD010585. doi:10.1002/14651858.CD010585.pub2. PMC 6491103 $2. PMID 29457627.
- van den Beuken-van Everdingen MH, de Graeff A, Jongen JL, Dijkstra D, Mostovaya I, Vissers KC (March 2017). "Pharmacological Treatment of Pain in Cancer Patients: The Role of Adjuvant Analgesics, a Systematic Review". Pain Practice. 17 (3): 409-419. doi:10.1111/papr.12459. PMID 27207115.
- Loder E, Rizzoli P (November 2018). "Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018". Headache. 58 (Suppl 3): 218-229. doi:10.1111/head.13375. PMID 30137671.
- Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz EM, Gloss D, Holler-Managan Y, Leininger E, Licking N, Mack K, Powers SW, Sowell M, Victorio MC, Yonker M, Zanitsch H, Hershey AD (September 2019). "Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society". Neurology. 93 (11): 500-509. doi:10.1212/WNL.0000000000008105. PMC 6746206 $2. PMID 31413170.
- Ghadiri-Sani M, Silver N (February 2016). "Headache (chronic tension-type)". BMJ Clinical Evidence. 2016. PMC 4747324 $2. PMID 26859719.
- Do TM, Unis GD, Kattar N, Ananth A, McCoul ED (June 2021). "Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis". The Laryngoscope. 131 (6): 1235-1253. doi:10.1002/lary.29162. PMID 33037835.
- Trinkley KE, Nahata MC (2014). "Medication management of irritable bowel syndrome". Digestion. 89 (4): 253-267. doi:10.1159/000362405 . PMID 24992947.
- Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA (November 2023). "Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial". Lancet. 402 (10414): 1773-1785. doi:10.1016/s0140-6736(23)01523-4. PMID 37858323.
- Venkatesan T, Levinthal DJ, Tarbell SE, Jaradeh SS, Hasler WL, Issenman RM, Adams KA, Sarosiek I, Stave CD, Sharaf RN, Sultan S, Li BU (June 2019). "Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association". Neurogastroenterology and Motility. 31 (Suppl 2): e13604. doi:10.1111/nmo.13604. PMC 6899751 $2. PMID 31241819.
- Caldwell PH, Sureshkumar P, Wong WC (January 2016). "Tricyclic and related drugs for nocturnal enuresis in children". The Cochrane Database of Systematic Reviews. 2016 (1): CD002117. doi:10.1002/14651858.CD002117.pub2. PMC 8741207 $2. PMID 26789925.
- Giusto LL, Zahner PM, Shoskes DA (July 2018). "An evaluation of the pharmacotherapy for interstitial cystitis". Expert Opinion on Pharmacotherapy. 19 (10): 1097-1108. doi:10.1080/14656566.2018.1491968. PMID 29972328.
- Colemeadow J, Sahai A, Malde S (2020). "Clinical Management of Bladder Pain Syndrome/Interstitial Cystitis: A Review on Current Recommendations and Emerging Treatment Options". Research and Reports in Urology. 12: 331-343. doi:10.2147/RRU.S238746 . PMC 7455607 $2. PMID 32904438.
- Everitt H, McDermott L, Leydon G, Yules H, Baldwin D, Little P (February 2014). "GPs' management strategies for patients with insomnia: a survey and qualitative interview study". The British Journal of General Practice. 64 (619): e112-e119. doi:10.3399/bjgp14X677176. PMC 3905408 $2. PMID 24567616.
- Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CC, Wilson S (May 2018). "Antidepressants for insomnia in adults". The Cochrane Database of Systematic Reviews. 2018 (5): CD010753. doi:10.1002/14651858.CD010753.pub2. PMC 6494576 $2. PMID 29761479.
- Pecknold JC, Luthe L (1989). "Trimipramine, anxiety, depression and sleep". Drugs. 38 (Suppl 1): 25-31; discussion 49-50. doi:10.2165/00003495-198900381-00007. PMID 2693052.
- Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M (September 2002). "Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study". Pharmacopsychiatry. 35 (5): 165-74. doi:10.1055/s-2002-34119. PMID 12237787.
- Berger M, Gastpar M (1996). "Trimipramine: a challenge to current concepts on antidepressives". European Archives of Psychiatry and Clinical Neuroscience. 246 (5): 235-9. doi:10.1007/BF02190274. PMID 8863001.
- Klein T, Woo TM, Panther S, Odom-Maryon T, Daratha K (2019). "Somnolence-Producing Agents: A 5-Year Study of Prescribing for Medicaid-Insured Children With Attention Deficit Hyperactivity Disorder". Journal of Pediatric Health Care. 33 (3): e1-e8. doi:10.1016/j.pedhc.2018.10.002. PMID 30630642.
- Domecq JP, Prutsky G, Leppin A, Sonbol MB, Altayar O, Undavalli C, Wang Z, Elraiyah T, Brito JP, Mauck KF, Lababidi MH, Prokop LJ, Asi N, Wei J, Fidahussein S, Montori VM, Murad MH (February 2015). "Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis". The Journal of Clinical Endocrinology and Metabolism. 100 (2): 363-370. doi:10.1210/jc.2014-3421. PMC 5393509 $2. PMID 25590213.
- Leucht C, Huhn M, Leucht S (December 2012). "Amitriptyline versus placebo for major depressive disorder". The Cochrane Database of Systematic Reviews. 12: CD009138. doi:10.1002/14651858.CD009138.pub2. PMID 23235671.
- Thour A, Marwaha R (18 Temmuz 2023). "Amitriptyline". StatPearls. Treasure Island, Florida: StatPearls Publishing. PMID 30725910. Erişim tarihi: 18 Mart 2024.
- Chen LW, Chen MY, Lian ZP, Lin HS, Chien CC, Yin HL, Chu YH, Chen KY (March 2018). "Amitriptyline and Sexual Function: A Systematic Review Updated for Sexual Health Practice". American Journal of Men's Health. 12 (2): 370-379. doi:10.1177/1557988317734519. PMC 5818113 $2. PMID 29019272.
- Amitriptyline. National Institute of Diabetes and Digestive and Kidney Diseases. 6 Ocak 2012. PMID 31643729. 21 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Ocak 2021 – PubMed vasıtasıyla.
- Voican CS, Corruble E, Naveau S, Perlemuter G (April 2014). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404-415. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450.
- Zemrak WR, Kenna GA (June 2008). "Association of antipsychotic and antidepressant drugs with Q-T interval prolongation". American Journal of Health-System Pharmacy. 65 (11): 1029-1038. doi:10.2146/ajhp070279. PMID 18499875. 21 Aralık 2016 tarihinde kaynağından arşivlendi.
- Campleman SL, Brent J, Pizon AF, Shulman J, Wax P, Manini AF (December 2020). "Drug-specific risk of severe QT prolongation following acute drug overdose". Clinical Toxicology. 58 (12): 1326-1334. doi:10.1080/15563650.2020.1746330. PMC 7541562 $2. PMID 32252558.
- Hefner G, Hahn M, Hohner M, Roll SC, Klimke A, Hiemke C (January 2019). "QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric Inpatients". Pharmacopsychiatry. 52 (1): 38-43. doi:10.1055/s-0044-102009. PMID 29466824.
- Muhammad M. Khalid; Muhammad Waseem. Tricyclic Antidepressant Toxicity. 13 Ekim 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- Tatsumi M, Groshan K, Blakely RD, Richelson E (December 1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". European Journal of Pharmacology. 340 (2–3): 249-258. doi:10.1016/s0014-2999(97)01393-9. PMID 9537821.
- Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (December 1997). "Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites". The Journal of Pharmacology and Experimental Therapeutics. 283 (3): 1305-1322. PMID 9400006.
- Cusack B, Nelson A, Richelson E (May 1994). "Binding of antidepressants to human brain receptors: focus on newer generation compounds". Psychopharmacology. 114 (4): 559-565. doi:10.1007/bf02244985. PMID 7855217.
- Peroutka SJ (May 1988). "Antimigraine drug interactions with serotonin receptor subtypes in human brain". Annals of Neurology. 23 (5): 500-504. doi:10.1002/ana.410230512. PMID 2898916.
- Peroutka SJ (August 1986). "Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex". Journal of Neurochemistry. 47 (2): 529-540. doi:10.1111/j.1471-4159.1986.tb04532.x. PMID 2942638.
- Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H (May 1996). "Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache?". The European Journal of Neuroscience. 8 (5): 959-967. doi:10.1111/j.1460-9568.1996.tb01583.x. PMID 8743744.
- Pälvimäki EP, Roth BL, Majasuo H, Laakso A, Kuoppamäki M, Syvälahti E, Hietala J (August 1996). "Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor". Psychopharmacology. 126 (3): 234-240. doi:10.1007/bf02246453. PMID 8876023.
- Sánchez C, Hyttel J (August 1999). "Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding". Cellular and Molecular Neurobiology. 19 (4): 467-489. doi:10.1023/a:1006986824213. PMID 10379421.
- Schmidt AW, Hurt SD, Peroutka SJ (November 1989). "'[3H]quipazine' degradation products label 5-HT uptake sites". European Journal of Pharmacology. 171 (1): 141-143. doi:10.1016/0014-2999(89)90439-1. PMID 2533080.
- Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (January 1996). "Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor". Journal of Neurochemistry. 66 (1): 47-56. doi:10.1046/j.1471-4159.1996.66010047.x. PMID 8522988.
- Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD (December 2003). "Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling". Molecular Pharmacology. 64 (6): 1295-1308. doi:10.1124/mol.64.6.1295. PMID 14645659.
- Monsma FJ, Shen Y, Ward RP, Hamblin MW, Sibley DR (March 1993). "Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs". Molecular Pharmacology. 43 (3): 320-327. PMID 7680751.
- Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (August 1993). "Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype". The Journal of Biological Chemistry. 268 (24): 18200-18204. doi:10.1016/S0021-9258(17)46830-X . PMID 8394362.
- Nojimoto FD, Mueller A, Hebeler-Barbosa F, Akinaga J, Lima V, Kiguti LR, Pupo AS (2010). "The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha1B-adrenoceptors". Neuropharmacology. 59 (1–2): 49-57. doi:10.1016/j.neuropharm.2010.03.015. PMID 20363235.
- Proudman RG, Pupo AS, Baker JG (August 2020). "The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors". Pharmacology Research & Perspectives. 8 (4): e00602. doi:10.1002/prp2.602. PMC 7327383 $2. PMID 32608144.
- Fallarero A, Pohjanoksa K, Wissel G, Parkkisenniemi-Kinnunen UM, Xhaard H, Scheinin M, Vuorela P (December 2012). "High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors". European Journal of Pharmaceutical Sciences. 47 (5): 941-951. doi:10.1016/j.ejps.2012.08.021. PMID 22982401.
- Bylund DB, Snyder SH (July 1976). "Beta adrenergic receptor binding in membrane preparations from mammalian brain". Molecular Pharmacology. 12 (4): 568-580. PMID 8699.
- von Coburg Y, Kottke T, Weizel L, Ligneau X, Stark H (January 2009). "Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics". Bioorganic & Medicinal Chemistry Letters. 19 (2): 538-542. doi:10.1016/j.bmcl.2008.09.012. PMID 19091563.
- Appl H, Holzammer T, Dove S, Haen E, Strasser A, Seifert R (February 2012). "Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics". Naunyn-Schmiedeberg's Archives of Pharmacology. 385 (2): 145-170. doi:10.1007/s00210-011-0704-0. PMID 22033803.
- Ghoneim OM, Legere JA, Golbraikh A, Tropsha A, Booth RG (October 2006). "Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes". Bioorganic & Medicinal Chemistry. 14 (19): 6640-6658. doi:10.1016/j.bmc.2006.05.077. PMID 16782354.
- Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF (March 2001). "Discovery of a novel member of the histamine receptor family". Molecular Pharmacology. 59 (3): 427-433. doi:10.1124/mol.59.3.427. PMID 11179435. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2019.
- Stanton T, Bolden-Watson C, Cusack B, Richelson E (June 1993). "Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics". Biochemical Pharmacology. 45 (11): 2352-2354. doi:10.1016/0006-2952(93)90211-e. PMID 8100134.
- Bymaster FP, Nelson DL, DeLapp NW, Falcone JF, Eckols K, Truex LL, Foreman MM, Lucaites VL, Calligaro DO (May 1999). "Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro". Schizophrenia Research. 37 (1): 107-122. doi:10.1016/s0920-9964(98)00146-7. PMID 10227113.
- Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JF (November 1986). "1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs". Proceedings of the National Academy of Sciences of the United States of America. 83 (22): 8784-8788. Bibcode:1986PNAS...83.8784W. doi:10.1073/pnas.83.22.8784 . PMC 387016 $2. PMID 2877462.
- Werling LL, Keller A, Frank JG, Nuwayhid SJ (October 2007). "A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder". Experimental Neurology. 207 (2): 248-257. doi:10.1016/j.expneurol.2007.06.013. PMID 17689532.
- Jo SH, Youm JB, Lee CO, Earm YE, Ho WK (April 2000). "Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline". British Journal of Pharmacology. 129 (7): 1474-1480. doi:10.1038/sj.bjp.0703222. PMC 1571977 $2. PMID 10742304.
- Yamakawa Y, Furutani K, Inanobe A, Ohno Y, Kurachi Y (February 2012). "Pharmacophore modeling for hERG channel facilitation". Biochemical and Biophysical Research Communications. 418 (1): 161-166. doi:10.1016/j.bbrc.2011.12.153. PMID 22244872.
- Fu L, Wang S, Wang X, Wang P, Zheng Y, Yao D, Guo M, Zhang L, Ouyang L (December 2016). "Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer". Scientific Reports. 6 (1): 3. doi:10.1038/s41598-016-0007-2. PMC 5431371 $2. PMID 28442756.
- Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K (June 2009). "Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity". Chemistry & Biology. 16 (6): 644-656. doi:10.1016/j.chembiol.2009.05.010. PMC 2844702 $2. PMID 19549602.
- Horishita T, Yanagihara N, Ueno S, Okura D, Horishita R, Minami T, Ogata Y, Sudo Y, Uezono Y, Sata T, Kawasaki T (December 2017). "Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes". Naunyn-Schmiedeberg's Archives of Pharmacology. 390 (12): 1255-1270. doi:10.1007/s00210-017-1424-x. PMID 28905186.
- Atkin TA, Maher CM, Gerlach AC, Gay BC, Antonio BM, Santos SC, Padilla KM, Rader J, Krafte DS, Fox MA, Stewart GR, Petrovski S, Devinsky O, Might M, Petrou S, Goldstein DB (April 2018). "A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy". Epilepsia. 59 (4): 802-813. doi:10.1111/epi.14037 . PMID 29574705.
- Nau C, Seaver M, Wang SY, Wang GK (March 2000). "Block of human heart hH1 sodium channels by amitriptyline". The Journal of Pharmacology and Experimental Therapeutics. 292 (3): 1015-1023. PMID 10688618.
- Punke MA, Friederich P (May 2007). "Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels". Anesthesia and Analgesia. 104 (5): 1256-64, tables of contents. doi:10.1213/01.ane.0000260310.63117.a2 . PMID 17456683. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2009.
- Villatoro-Gómez K, Pacheco-Rojas DO, Moreno-Galindo EG, Navarro-Polanco RA, Tristani-Firouzi M, Gazgalis D, Cui M, Sánchez-Chapula JA, Ferrer T (June 2018). "Molecular determinants of Kv7.1/KCNE1 channel inhibition by amitriptyline". Biochemical Pharmacology. 152: 264-271. doi:10.1016/j.bcp.2018.03.016. PMID 29621539.
- Jo SH, Youm JB, Lee CO, Earm YE, Ho WK (April 2000). "Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline". British Journal of Pharmacology. 129 (7): 1474-1480. doi:10.1038/sj.bjp.0703222. PMC 1571977 $2. PMID 10742304.
- McClure EW, Daniels RN (February 2021). "Classics in Chemical Neuroscience: Amitriptyline". ACS Chemical Neuroscience. 12 (3): 354-362. doi:10.1021/acschemneuro.0c00467. PMID 33438398.
- Schulz P, Dick P, Blaschke TF, Hollister L (1985). "Discrepancies between pharmacokinetic studies of amitriptyline". Clinical Pharmacokinetics. 10 (3): 257-268. doi:10.2165/00003088-198510030-00005. PMID 3893842.
- Breyer-Pfaff U (October 2004). "The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man". Drug Metabolism Reviews. 36 (3–4): 723-746. doi:10.1081/dmr-200033482. PMID 15554244.
- Venkatakrishnan K, Schmider J, Harmatz JS, Ehrenberg BL, von Moltke LL, Graf JA, Mertzanis P, Corbett KE, Rodriguez MC, Shader RI, Greenblatt DJ (October 2001). "Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies". Journal of Clinical Pharmacology. 41 (10): 1043-1054. doi:10.1177/00912700122012634. PMID 11583471.
- Nordin C, Bertilsson L (January 1995). "Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline". Clinical Pharmacokinetics. 28 (1): 26-40. doi:10.2165/00003088-199528010-00004. PMID 7712660.
- Dawlilng S, Lynn K, Rosser R, Braithwaite R (July 1981). "The pharmacokinetics of nortriptyline in patients with chronic renal failure". British Journal of Clinical Pharmacology. 12 (1): 39-45. doi:10.1111/j.1365-2125.1981.tb01852.x. PMC 1401753 $2. PMID 7248140.
dailymed.nlm.nih.gov
- "DailyMed – AMITRIPTYLINE HYDROCHLORIDE tablet, film coated". 25 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 2 Şubat 2021.
nihr.ac.uk
evidence.nihr.ac.uk
- "Combination therapy for painful diabetic neuropathy is safe and effective". NIHR Evidence (İngilizce). 6 Nisan 2023. doi:10.3310/nihrevidence_57470. 28 Nisan 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- "Irritable bowel syndrome: low-dose antidepressant improves symptoms". NIHR Evidence. National Institute for Health and Care Research (NIHR). 26 Mart 2024. doi:10.3310/nihrevidence_62555. 18 Mayıs 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
tga.gov.au
ebs.tga.gov.au
- "Endep Amitriptyline hydrochloride" (PDF). TGA eBusiness Services. Alphapharm Pty Limited. 10 Aralık 2012. 13 Ağustos 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Aralık 2013.
unc.edu
pdsp.unc.edu
- Roth BL, Driscol J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Ağustos 2017.
cdr.lib.unc.edu
- Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF (March 2001). "Discovery of a novel member of the histamine receptor family". Molecular Pharmacology. 59 (3): 427-433. doi:10.1124/mol.59.3.427. PMID 11179435. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2019.
web.archive.org
- "Amitriptyline Tablets BP 50mg – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Actavis UK Ltd. 24 Mart 2013. 3 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Aralık 2013.
- "Amitriptyline Hydrochloride". The American Society of Health-System Pharmacists. 24 Eylül 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 25 Eylül 2014.
- "The Top 300 of 2019". ClinCalc. 16 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ekim 2021.
- "Amitriptyline - Drug Usage Statistics". ClinCalc. 30 Nisan 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Ekim 2021.
- "Parkinson's disease". merckmanuals.com. Merck Sharp & Dohme Corp. August 2007. 18 Kasım 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Aralık 2013.
- "Combination therapy for painful diabetic neuropathy is safe and effective". NIHR Evidence (İngilizce). 6 Nisan 2023. doi:10.3310/nihrevidence_57470. 28 Nisan 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- "Elavil for MS". nationalmssociety.org. 7 Temmuz 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Temmuz 2023.
- "Irritable bowel syndrome: low-dose antidepressant improves symptoms". NIHR Evidence. National Institute for Health and Care Research (NIHR). 26 Mart 2024. doi:10.3310/nihrevidence_62555. 18 Mayıs 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- Amitriptyline. National Institute of Diabetes and Digestive and Kidney Diseases. 6 Ocak 2012. PMID 31643729. 21 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Ocak 2021 – PubMed vasıtasıyla.
- Zemrak WR, Kenna GA (June 2008). "Association of antipsychotic and antidepressant drugs with Q-T interval prolongation". American Journal of Health-System Pharmacy. 65 (11): 1029-1038. doi:10.2146/ajhp070279. PMID 18499875. 21 Aralık 2016 tarihinde kaynağından arşivlendi.
- "Amitriptyline Uses, Dosage, Side Effects, Warnings". Drugs.com (İngilizce). 19 Haziran 2024 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- Muhammad M. Khalid; Muhammad Waseem. Tricyclic Antidepressant Toxicity. 13 Ekim 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2024.
- "Endep Amitriptyline hydrochloride" (PDF). TGA eBusiness Services. Alphapharm Pty Limited. 10 Aralık 2012. 13 Ağustos 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Aralık 2013.
- Roth BL, Driscol J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 14 Ağustos 2017.
- Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF (March 2001). "Discovery of a novel member of the histamine receptor family". Molecular Pharmacology. 59 (3): 427-433. doi:10.1124/mol.59.3.427. PMID 11179435. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2019.
- Punke MA, Friederich P (May 2007). "Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels". Anesthesia and Analgesia. 104 (5): 1256-64, tables of contents. doi:10.1213/01.ane.0000260310.63117.a2 . PMID 17456683. 27 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 15 Ekim 2009.
- "DailyMed – AMITRIPTYLINE HYDROCHLORIDE tablet, film coated". 25 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 2 Şubat 2021.
- "Pamelor, Aventyl (nortriptyline) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. 3 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 2 Aralık 2013.
wiley.com
doi.wiley.com
- Leucht, Claudia; Huhn, Maximilian; Leucht, Stefan (12 Aralık 2012). Cochrane Common Mental Disorders Group (Ed.). "Amitriptyline versus placebo for major depressive disorder". Cochrane Database of Systematic Reviews (İngilizce). doi:10.1002/14651858.CD009138.pub2.